International, Peer Reviewed, Open Access Journal

Annals of Integrative Molecular Medicine

Submit Manuscript

Annals of Integrative Molecular Medicine

Annals of Integrative Molecular Medicine (ISSN 2690-0319) s a peer- reviewed, open access, scientific journal published by Medtext Publications with an aim to highlights the work on biological, molecular, biomedicine research.

Journal Features

Open Access

All the articles will be published under Open Access model.

Peer Review

Our editorial team performs strict peer-review process.

Publication Ethics

The journal follows standard guidelines to maintain transparency.

Submit Manuscript

The journal accepts all original articles, reviews and more.

About the Journal

Annals of Integrative Molecular Medicine (ISSN 2690-0319) is a peer- reviewed, open access, scientific journal published by Medtext Publications with an aim to highlights the work on biological, molecular, biomedicine research and providing useful source of dissemination in the form of Original articles, Review article, Case reports, Case series, Editorial, Perspectives, Short Communications, Surgical techniques on all related latest novel discovery, current innovations etc.,   Medtext Publications is one of emerging open access publishing company which is self- financed and does not receives funds from any government or institution. The journal finance is handled by fees received from authors and some from academic/institutional sponsors   We will ensure and strive that Annals of Integrative Molecular Medicine maintain the standard accordingly in peer review, Editing, publishing etc., and encourages our researchers, scientists, academicians, clinicians and other expertise to publish their work to our journal.   Medtext Publications works diligently on peer review process from reviewers among which two independent reviews are taken in to considerations. Since it is an open access, articles published by this journal are freely available on internet to read, download without subscribing and can visit infinite time.   Annals of Integrative Molecular Medicine aims to maintain the fast publishing service and also seeks to introduce Thematic Issue with emerging topics, current innovations, novel trends, new drug entity discoveries, treatment regimens and enhancing the journal citation. We highlight on quality with time and at least three weeks for acceptance and this is achieved by great support from our Editorial Board Members who are having a crucial role in the journal development, aid in reviewing assigned articles, exchanging their ideas and advising for journal growth and also contribute in manuscript submission.   Our ultimate goal is to provide broad spectrum of useful and reliable source of information on rare and common disorders from Epidemiology, Etiology, causes and Treatment and to make readers aware of Molecular Medicine.

Open Access - Annals of Integrative Molecular Medicine

Articles

Ann Integr Mol Med. 2021;2(1):AIMM-02-1009 | Open Access

News from Mars: Two-Tier Paradox, Intracellular PCR, Chimeric Junction Shift, Dark Matter mRNA and Other Remarkable Features of Mammalian RNA-Dependent mRNA Amplification. Implications for Alzheimer’s Disease, RNA-Based Vaccines and mRNA Therapeutics

Vladimir Volloch1* and Sophia Rits-Volloch2,3

PERSPECTIVE Updated Feb 04, 2021   PDF

Ann Integr Mol Med. 2020;2(1):AIMM-02-1008 | Open Access

Alzheimers Disease Prevention and Treatment: Case for Optimism

Vladimir Volloch, Bjorn Olsen and Sophia Rits

PERSPECTIVE Updated Aug 12, 2020   PDF

Ann Integr Mol Med. 2020;2(1):AIMM-1007 | Open Access

Alzheimer’s Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow

Vladimir Volloch1*, Bjorn Olsen1 and Sophia Rits2,3

PERSPECTIVE Updated Apr 08, 2020   PDF

Ann Integr Mol Med. 2020;2(1):AIMM-01-1006 | Open Access

AD “Statin”: Alzheimer’s Disorder is a “Fast” Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages

Vladimir Volloch, Bjorn R Olsen and Sophia Rits

PERSPECTIVE Updated Jan 06, 2020   PDF

Ann Integr Mol Med. 2019;1(1):AIMM-01-1005 | Open Access

Precursor-Independent Overproduction of Beta- Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer’s Disease

Vladimir Volloch, Bjorn R Olsen and Sophia Rits

REVIEW ARTICLE Updated Nov 20, 2019   PDF